Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents

Clinical Trial ID NCT00111345

Rank	Title	Journal	Year	PubWeight™‹?›
1	Treatment and prognostic impact of transient leukemia in neonates with Down syndrome.	Blood	2008	1.56
2	CNS irradiation in pediatric acute myleoid leukemia: equal results by 12 or 18 Gy in studies AML-BFM98 and 2004.	Pediatr Blood Cancer	2011	1.44
3	Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004.	Blood	2013	1.23
4	DNMT3A mutations are rare in childhood acute myeloid leukemia.	Haematologica	2011	0.85
5	Intact apoptosis signaling in myeloid leukemia cells determines treatment outcome in childhood AML.	Blood	2007	0.80
6	Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004.	Blood Cancer J	2016	0.79
7	Infectious Complications in Children With Acute Myeloid Leukemia and Down Syndrome: Analysis of the Prospective Multicenter Trial AML-BFM 2004.	Pediatr Blood Cancer	2016	0.78
8	Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia: An Analysis of the AML-BFM 2004 Trial.	J Clin Oncol	2016	0.76